{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:44:16Z","timestamp":1794930256842,"version":"4.9.1"},"reference-count":26,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>We performed a retrospective multicenter study including 791 patients with relapsed\/refractory (R\/R) large B-cell lymphoma (LBCL) who underwent autologous stem cell transplantation (ASCT). After a median follow-up of 74 months from infusion, 65% were alive and 84% free of disease. Progression-free survival (PFS) and overall survival (OS) at 6 years were 51% and 63%, respectively. Non-relapse mortality at 1 year was 9%. Age &amp;gt;60 years at ASCT (hazard ratio [HR], 1.31; 95% CI, 1.06-1.62; P = .011), ASCT as \u22653rd line (HR, 1.81; 95% CI, 1.42-2.31; P &amp;lt; .001), and partial response (PR) vs complete response (CR) at ASCT (HR, 1.46; 95% CI. 1.18-1.81; P &amp;lt; .001) were independent variables influencing PFS. Age &amp;gt;60 years at ASCT (HR, 1.62; 95% CI, 1.24-2.12; P &amp;lt; .001), time period before 1 November 2012 (HR, 1.40; 95% CI, 1.07-1.83; P = .014), ASCT as \u22653rd line (HR, 1.77; 95% CI, 1.32-2.37; P &amp;lt; .001), PR vs CR (HR, 1.58; 95% CI, 1.22-2.05; P &amp;lt; .001), and stable disease vs CR pre-ASCT (HR, 3.41; 95% CI, 1.81-6.45; P &amp;lt; .001) were variables associated with worse OS. Refractory\/early relapse did not significantly influence survival (6-year PFS and OS in patients with refractory, early, and late relapse were 54% and 64%, 46% and 62%, and 49% and 63%, respectively). To our knowledge, this is the largest series analyzing the efficacy of ASCT in patients with R\/R LBCL after rituximab-containing frontline therapy. Our results indicate that ASCT is a curative option for patients with chemosensitive disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015415","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:15:17Z","timestamp":1743448517000},"page":"3281-3292","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Autologous stem cell transplantation for relapsed\/refractory large B-cell lymphoma: a multicenter GETH-TC\/GELTAMO study"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9929-8617","authenticated-orcid":false,"given":"Leyre","family":"Bento","sequence":"first","affiliation":[{"name":"1Hospital Universitario Son Espases, Instituto de Investigaci\u00f3n Sanitaria de Baleares, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-1728","authenticated-orcid":false,"given":"Antonio","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"1Hospital Universitario Son Espases, Instituto de Investigaci\u00f3n Sanitaria de Baleares, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"2Hospital Clinic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Consejo","family":"Ort\u00ed Verdet","sequence":"additional","affiliation":[{"name":"3Hospital La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sorribes","sequence":"additional","affiliation":[{"name":"4Hospital Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-5259","authenticated-orcid":false,"given":"Ana Carolina","family":"Caballero","sequence":"additional","affiliation":[{"name":"4Hospital Santa Creu i Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-7276","authenticated-orcid":false,"given":"Marta","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"5Hospital Duran i Reynals-Institut Catal\u00e0 d\u2019Oncologia-Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-2130","authenticated-orcid":false,"given":"Ariadna","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"6Hospital Cl\u00ednico Valencia, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jim\u00e9nez-Ubieto","sequence":"additional","affiliation":[{"name":"7Hospital 12 Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5081-8466","authenticated-orcid":false,"given":"Luc\u00eda","family":"Medina","sequence":"additional","affiliation":[{"name":"7Hospital 12 Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9431-4646","authenticated-orcid":false,"given":"Mariana","family":"Bastos-Oreiro","sequence":"additional","affiliation":[{"name":"8Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Fern\u00e1ndez","family":"Caldas-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"8Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Navarro","sequence":"additional","affiliation":[{"name":"9Hospital Universitario Puerta de Hierro, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1976-320X","authenticated-orcid":false,"given":"Isabel","family":"Salcedo","sequence":"additional","affiliation":[{"name":"9Hospital Universitario Puerta de Hierro, Majadahonda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Abrisqueta","sequence":"additional","affiliation":[{"name":"10Hospital Vall D`Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Espa\u00f1ol","sequence":"additional","affiliation":[{"name":"11Hospital Universitario Virgen de Arrixaca, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0737-4211","authenticated-orcid":false,"given":"Javier","family":"Cornago","sequence":"additional","affiliation":[{"name":"12Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-6731","authenticated-orcid":false,"given":"Fernando","family":"Mart\u00edn-Moro","sequence":"additional","affiliation":[{"name":"13Hospital Universitario Ram\u00f3n y Cajal, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"14Hospital Morales Meseguer, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"15Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-6668","authenticated-orcid":false,"given":"Mar\u00eda Rosario","family":"Varela","sequence":"additional","affiliation":[{"name":"16Complejo Hospitalario Universitario A Coru\u00f1a, Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Puente","sequence":"additional","affiliation":[{"name":"17Hospital Universitario Marqu\u00e9s de Valdecilla, Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joud","family":"Zanabili","sequence":"additional","affiliation":[{"name":"18Hospital Universitario Central de Asturias, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4009-9354","authenticated-orcid":false,"given":"Teresa","family":"Zudaire","sequence":"additional","affiliation":[{"name":"19Hospital Universitario de Navarra, Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8760-2714","authenticated-orcid":false,"given":"Izaskun","family":"Zeberio","sequence":"additional","affiliation":[{"name":"20Hospital Universitario Donostia, San Sebasti\u00e1n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"del Campo","sequence":"additional","affiliation":[{"name":"21Hospital Universitario Son Ll\u00e0tzer, IdISBa, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"22Hospital Universitario de Gran Canaria Dr. Negr\u00edn, Las Palmas, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"23Hospital Universitario Virgen de las Nieves, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[{"name":"24Hospital Universitario Virgen del Roc\u00edo, Instituto de Biomedicina de Sevilla, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordina","family":"Rovira","sequence":"additional","affiliation":[{"name":"25Hospital Universitari de Tarragona Joan XXIII, Institut Catal\u00e0 d`Oncologia, Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sitges","sequence":"additional","affiliation":[{"name":"26Hospital Universitari Doctor Josep Trueta, Institut Catal\u00e0 d`Oncologia, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Franch-Sarto","sequence":"additional","affiliation":[{"name":"27ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Cabero","sequence":"additional","affiliation":[{"name":"28Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4088-036X","authenticated-orcid":false,"given":"Alberto","family":"Mussetti","sequence":"additional","affiliation":[{"name":"5Hospital Duran i Reynals-Institut Catal\u00e0 d\u2019Oncologia-Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-8068","authenticated-orcid":false,"given":"Juan","family":"Montoro","sequence":"additional","affiliation":[{"name":"3Hospital La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7465-6203","authenticated-orcid":false,"given":"Antonia","family":"Sampol","sequence":"additional","affiliation":[{"name":"1Hospital Universitario Son Espases, Instituto de Investigaci\u00f3n Sanitaria de Baleares, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-6970","authenticated-orcid":false,"given":"Anna","family":"Sureda","sequence":"additional","affiliation":[{"name":"5Hospital Duran i Reynals-Institut Catal\u00e0 d\u2019Oncologia-Hospitalet, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Caballero","sequence":"additional","affiliation":[{"name":"28Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-1028","authenticated-orcid":false,"given":"Alejandro","family":"Mart\u00edn Garc\u00eda-Sancho","sequence":"additional","affiliation":[{"name":"28Hospital Universitario de Salamanca, University of Salamanca, Salamanca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"1","key":"2025070811265293500_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/bmt.2015.213","article-title":"Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the international CORAL study","volume":"51","author":"Van Den Neste","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"2025070811265293500_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbmt.2011.10.010","article-title":"High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation registry","volume":"18","author":"Mounier","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"issue":"23","key":"2025070811265293500_bib3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"27","key":"2025070811265293500_bib4","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"issue":"31","key":"2025070811265293500_bib5","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2013.53.9593","article-title":"Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12","volume":"32","author":"Crump","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"2025070811265293500_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1200\/JCO.2016.69.0198","article-title":"Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: the ORCHARRD study","volume":"35","author":"van Imhoff","year":"2017","journal-title":"J Clin Oncol"},{"issue":"7","key":"2025070811265293500_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"N Engl J Med"},{"issue":"10343","key":"2025070811265293500_bib8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/S0140-6736(22)00662-6","article-title":"Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial","volume":"399","author":"Kamdar","year":"2022","journal-title":"The Lancet"},{"issue":"2","key":"2025070811265293500_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa2301665","article-title":"Survival with axicabtagene ciloleucel in large B-cell lymphoma","volume":"389","author":"Westin","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"2025070811265293500_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"27","key":"2025070811265293500_bib11","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"issue":"31","key":"2025070811265293500_bib12","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2013.53.9593","article-title":"Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12","volume":"32","author":"Crump","year":"2014","journal-title":"J Clin Oncol"},{"issue":"12","key":"2025070811265293500_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3324\/haematol.13440","article-title":"R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL\/TAMO study","volume":"93","author":"Martin","year":"2008","journal-title":"Haematologica"},{"issue":"16","key":"2025070811265293500_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","article-title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","volume":"130","author":"Crump","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2025070811265293500_bib15","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.32752","article-title":"Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation","volume":"126","author":"Jagadeesh","year":"2020","journal-title":"Cancer"},{"issue":"11","key":"2025070811265293500_bib16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.bbmt.2014.06.036","article-title":"Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation","volume":"20","author":"Hamadani","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"2025070811265293500_bib17","doi-asserted-by":"crossref","first-page":"55.e1","DOI":"10.1016\/j.bbmt.2020.09.004","article-title":"Outcomes of autologous hematopoietic cell transplantation in diffuse large B cell lymphoma refractory to firstline chemoimmunotherapy","volume":"27","author":"Bal","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"9","key":"2025070811265293500_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtct.2023.06.012","article-title":"ASTCT clinical practice recommendations for transplantation and cellular therapies in diffuse large B cell lymphoma","volume":"29","author":"Epperla","year":"2023","journal-title":"Transpl Cell Ther"},{"issue":"9","key":"2025070811265293500_bib19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2021013289","article-title":"Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission","volume":"139","author":"Shadman","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025070811265293500_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41408-024-01084-w","article-title":"Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission","volume":"14","author":"Shadman","year":"2024","journal-title":"Blood Cancer J"},{"issue":"1","key":"2025070811265293500_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2010.08162.x","article-title":"Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy","volume":"150","author":"Dickinson","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2025070811265293500_bib22","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/bjh.15713","article-title":"Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group","volume":"184","author":"Redondo","year":"2019","journal-title":"Br J Haematol"},{"issue":"10","key":"2025070811265293500_bib23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1182\/blood.2020007939","article-title":"Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?","volume":"137","author":"Shah","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2025070811265293500_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2016.68.2740","article-title":"Relapsed or refractory double-expressor and double-hit lymphomas have inferior progression-free survival after autologous stem-cell transplantation","volume":"35","author":"Herrera","year":"2017","journal-title":"J Clin Oncol"},{"issue":"20","key":"2025070811265293500_bib25","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2025070811265293500_bib26","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/13\/3281\/2383145\/blooda_adv-2024-015415-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/13\/3281\/2383145\/blooda_adv-2024-015415-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:27:00Z","timestamp":1751988420000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/13\/3281\/536427\/Autologous-stem-cell-transplantation-for-relapsed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,7,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015415","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,8]]},"published":{"date-parts":[[2025,6,27]]}}}